FOLD (STOCKS)
Amicus Therapeutics, Inc
$14.460000
+0.000000 (+0.00%)
Prev close: $14.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Bradley Lewis Campbell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,540.45M
- Employees
- 499
- P/E (TTM)
- -163.21
- P/B (TTM)
- 16.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $634.21M |
| Benefits Costs and Expenses | $634.02M |
| Cost Of Revenue | $72.93M |
| Costs And Expenses | $634.02M |
| Gross Profit | $561.28M |
| Operating Expenses | $528.49M |
| Selling, General, and Administrative Expenses | $383.49M |
| Other Operating Expenses | $145.01M |
| Operating Income/Loss | $32.79M |
| Income/Loss From Continuing Operations After Tax | -$27.11M |
| Income/Loss From Continuing Operations Before Tax | $191.00K |
| Income Tax Expense/Benefit | $27.30M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$27.11M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.11M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.11M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.09 |
| Basic Average Shares | 308,363,768 |
| Diluted Average Shares | 308,363,768 |
| Assets | $949.87M |
| Current Assets | $676.17M |
| Inventory | $228.82M |
| Other Current Assets | $447.35M |
| Noncurrent Assets | $273.70M |
| Fixed Assets | $27.11M |
| Intangible Assets | $13.92M |
| Other Non-current Assets | $232.67M |
| Liabilities | $675.63M |
| Current Liabilities | $237.83M |
| Accounts Payable | $28.63M |
| Wages | $37.68M |
| Other Current Liabilities | $171.52M |
| Noncurrent Liabilities | $437.80M |
| Long-term Debt | $392.66M |
| Other Non-current Liabilities | $45.14M |
| Equity | $274.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $274.24M |
| Liabilities And Equity | $949.87M |
| Net Cash Flow From Operating Activities | $33.15M |
| Net Cash Flow From Operating Activities, Continuing | $33.15M |
| Net Cash Flow From Investing Activities | -$46.43M |
| Net Cash Flow From Investing Activities, Continuing | -$46.43M |
| Net Cash Flow From Financing Activities | $610.00K |
| Net Cash Flow From Financing Activities, Continuing | $610.00K |
| Exchange Gains/Losses | $13.28M |
| Net Cash Flow | $600.00K |
| Net Cash Flow, Continuing | -$12.68M |
| Comprehensive Income/Loss | -$8.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.10M |
| Other Comprehensive Income/Loss | $19.01M |
| Other Comprehensive Income/Loss Attributable To Parent | $19.01M |